Wanas, H.; Elbadawy, H.M.; Almikhlafi, M.A.; Hamoud, A.E.; Ali, E.N.; Galal, A.M.
Combination of Niclosamide and Pirfenidone Alleviates Pulmonary Fibrosis by Inhibiting Oxidative Stress and MAPK/Nf-κB and STATs Regulated Genes. Pharmaceuticals 2023, 16, 697.
https://doi.org/10.3390/ph16050697
AMA Style
Wanas H, Elbadawy HM, Almikhlafi MA, Hamoud AE, Ali EN, Galal AM.
Combination of Niclosamide and Pirfenidone Alleviates Pulmonary Fibrosis by Inhibiting Oxidative Stress and MAPK/Nf-κB and STATs Regulated Genes. Pharmaceuticals. 2023; 16(5):697.
https://doi.org/10.3390/ph16050697
Chicago/Turabian Style
Wanas, Hanaa, Hossein M. Elbadawy, Mohannad A. Almikhlafi, Amany E. Hamoud, Eid N. Ali, and Amr M. Galal.
2023. "Combination of Niclosamide and Pirfenidone Alleviates Pulmonary Fibrosis by Inhibiting Oxidative Stress and MAPK/Nf-κB and STATs Regulated Genes" Pharmaceuticals 16, no. 5: 697.
https://doi.org/10.3390/ph16050697
APA Style
Wanas, H., Elbadawy, H. M., Almikhlafi, M. A., Hamoud, A. E., Ali, E. N., & Galal, A. M.
(2023). Combination of Niclosamide and Pirfenidone Alleviates Pulmonary Fibrosis by Inhibiting Oxidative Stress and MAPK/Nf-κB and STATs Regulated Genes. Pharmaceuticals, 16(5), 697.
https://doi.org/10.3390/ph16050697
